Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

Br J Cancer. 2020 Aug;123(3):495. doi: 10.1038/s41416-020-0879-6.

Mei Gao^{1

2}, Miranda Lin¹, Richard A Moffitt³, Marcela A Salazar⁴, Jinha Park⁵, Jeffrey Vacirca⁶, Chuan Huang^{7

8}, Kenneth R Shroyer³, Minsig Choi⁹, Georgios V Georgakis¹⁰, Aaron R Sasson¹⁰, Mark A Talamini¹⁰, Joseph Kim^{11

12}

¹ Department of Surgery, University of Kentucky, Lexington, KY, USA.
² Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
³ Department of Pathology, State University of New York, Stony Brook, NY, USA.
⁴ Department of Experimental Therapeutics, City of Hope, Duarte, CA, USA.
⁵ Department of Radiology, University of Iowa, Iowa City, IA, USA.
⁶ New York Cancer Specialists, East Setauket, New York, NY, USA.
⁷ Departments of Radiology, State University of New York, Stony Brook, NY, USA.
⁸ Departments of Psychiatry, State University of New York, Stony Brook, NY, USA.
⁹ Departments of Medicine, State University of New York, Stony Brook, NY, USA.
¹⁰ Departments of Surgery, State University of New York, Stony Brook, NY, USA.
¹¹ Department of Surgery, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.
¹² Markey Cancer Center, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.